__
Full publication of pivotal trial data outlines Akili’s case for FDA regulation (MobiHealthNews):
“A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission [Read more…] about Large study finds positive yet mixed results from Akili’s digital therapeutic for kids with ADHD